The orthobiologics market size is expected to cross the robust revenue mark by the end of 2033, growing at a CAGR of 6% during the forecast period (2023-2033). Trends in the global orthobiologics market such as weakened immunity and prevalence of calcium deficiency due to changing lifestyles and surge in spending on medical technologies are projected to positively impact the market growth during the forecast period.